Synchron Buys French Biomarker, Dx Services Lab for $6.7M | GenomeWeb
NEW YORK (GenomeWeb News) - Indian clinical research organization Synchron Research Services has acquired from Parexel a biomarker and bioanalytical research facility based in France for around $6.7 million, Synchron said today.
 
The lab, which is located in Poitiers, France, and was bought by Parexel in 1999, will now be called Synexel Research International. The lab offers singleplexed and multiplexed immunoassay platforms that support early clinical, pre-clinical, and clinical studies, as well as biomarker research programs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.